The article discusses research indicating that a peptide can block DNA breaks associated with treatment-induced leukemia, potentially offering a new prevention strategy. It explains that secondary leukemias can arise due to DNA damage caused by chemotherapy or radiotherapy, which may lead to harmful genetic rearrangements if improperly repaired.
Bias read (Center): The article presents scientific findings without overt ideological framing. It focuses on medical research and does not take a stance on political issues.
